Intervention Protocol

Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair

  1. Daniel John Quinlan1,*,
  2. John W Eikelboom2,
  3. James D Douketis3

Editorial Group: Cochrane Peripheral Vascular Diseases Group

Published Online: 21 JAN 2009

DOI: 10.1002/14651858.CD004179

Database Title

Additional Information

How to Cite

Quinlan DJ, Eikelboom JW, Douketis JD. Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair (Protocol). Cochrane Database of Systematic Reviews 2002, Issue 2. Art. No.: CD004179. DOI: 10.1002/14651858.CD004179.

Author Information

  1. 1

    Flat 51, St. George's Court, London, UK

  2. 2

    McMaster Clinic, Thrombosis Service, Hamilton, Ontario, Canada

  3. 3

    McMaster University and St. Josephs Hospital, Department of Medicine, East Hamilton, Ontario, Canada

*Daniel John Quinlan, Flat 51, St. George's Court, 258 Brompton Road, South Kensington, London, SW3 2AT, UK. dan.quinlan@consultoberon.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 21 JAN 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Full (114K)
 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The objective is to examine the efficacy and safety of extended-duration anticoagulant prophylaxis in patients undergoing elective hip or knee replacement surgery, or hip fracture repair, using all the available data from clinical trials involving the comparison of low molecular weight heparin, warfarin, unfractionated heparin, or other anticoagulants with placebo.

View Full Article (HTML) Full (114K)